Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2024 Jul 9;15(7):490. doi: 10.1038/s41419-024-06794-4

Correction: The HDAC inhibitor, MPT0E028, enhances erlotinib induced cell death in EGFR-TKI-resistant NSCLC cells

M -C Chen 1, C -H Chen 1, J -C Wang 2, A -C Tsai 1, J -P Liou 3,, S -L Pan 2,, C -M Teng 1,
PMCID: PMC11233614  PMID: 38982073

Correction to: Cell Death and Disease 10.1038/cddis.2013.330, published online 19 September 2013

In Figure 4e (Ac-tubulin) and Figure 5b (p-EGFR), the western blots were inadvertently misplaced during final figure preparation. The results have been confirmed by three replicates and the figures have been corrected accordingly. These corrections do not affect the results and conclusions of this study. We deeply apologize for any confusion or inconvenience that this may have caused. The original article has been corrected.

The original blots of three replicates for the correction of 4e:graphic file with name 41419_2024_6794_Figa_HTML.jpg

Corrected figure 4:graphic file with name 41419_2024_6794_Figb_HTML.jpg

The original blots of three replicates for the correction of 5b:graphic file with name 41419_2024_6794_Figc_HTML.jpg

Corrected figure 5:graphic file with name 41419_2024_6794_Figd_HTML.jpg

Contributor Information

J. -P Liou, Email: jpl@tmu.edu.tw.

S. -L Pan, Email: slpan@tmu.edu.tw.

C. -M Teng, Email: cmteng@ntu.edu.tw.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES